SCYNEXIS Stock

SCYNEXIS Minority Interest

Minority Interest (Non-Controlling Interest) of SCYNEXIS (SCYX) as of Aug 20, 2026.

Minority Interest

0.00USD

Last updated:

Minority Interest (Non-Controlling Interest) of SCYNEXIS is 2026 0.00 USD. Minority Interest (Non-Controlling Interest) of SCYNEXIS was 2025 0.00 USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Minority Interest (Non-Controlling Interest) SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Minority interest represents the portion of subsidiaries not owned by the parent company. It reflects third-party ownership stakes in consolidated entities.

Minority Interest (Non-Controlling Interest)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Minority Interest (Non-Controlling Interest)'s SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — SCYNEXIS

All Key Metrics — SCYNEXIS